Lyumjev – a fully closed loop case study with oref1
When Lyumjev, or URLi was announced, and pharmacodynamic details released back in September 2019, I noted that it had the potential to transform the use […]
Ultra Rapid Lispro
Clinical benefits of faster insulins – an n=1 answer to a common #EASD2020 question
Whilst watching EASD2020 this week, during the session on developing better insulins, a question was asked by multiple participants in relation to faster insulins. This […]
Lyumjev. What next? Another n=1 experiment…
Warning: What is discussed in this post is not recommended by the manufacturers and not aligned with the European Medicines Agency sign off for Lyumjev […]
Insulin Lyumjev… Not as URLi as I expected!
As readers of this page will be aware, I’ve been following Ultra Rapid Lispro for a little while, as Lilly has published various data at […]
Ultra-Rapid Lispro: What is it and why is it interesting?
In the second article in this series looking at ultra-rapid insulin, we talk about Lilly’s new kid on the block: Ultra-Rapid Lispro (URLi) Ultra-Rapid Lispro […]
“…Go faster. But don’t go stupid…” – A short series of articles on ultra-rapid insulins and closed loops
As we saw in a session at the EASD 2019 Conference, there are some interesting advances coming (or already here) in the realm of Ultra-Rapid […]